新闻
NBIX
--
0.00%
--
DJ Neurocrine将目标股价从126.00美元下调至112.00美元/股
Dow Jones · 12小时前
Wedbush维持DJ Neurocrine跑赢大盘
Dow Jones · 12小时前
全球子宫内膜异位疗法市场增长,现状和展望研究报告2026
Apr 12, 2021 (Heraldkeepers) -- The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size...
Heraldkeepers · 12小时前
预计2025年基本震颤治疗市场规模将达到5.3%的复合年增长率
Apr 09, 2021 (Market Insight Reports) -- According to this study, over the next five years the Essential Tremor Treatment market will register a 5.3%% CAGR...
Market Insight Reports · 3天前
Neurocrine Biosciences表示将在美国神经病学会第73届2021年虚拟会议上展示神经病学组合的数据
Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73rd 2021 Virtual Meeting SAN DIEGO, April 8, 2021 /PRNewswire/ -- Neurocrine Biosciences,
Benzinga · 4天前
Neurocrine Biosciences将在美国神经病学会第73届2021年虚拟会议上展示其神经病学组合的数据
SAN DIEGO, April 8, 2021 /PRNewswire via COMTEX/ -- SAN DIEGO, April 8, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that...
PR Newswire - PRF · 4天前
FDA的AccessData网站显示了用于Neurocrine Bioscience的癫痫性脑病治疗的孤儿药名称
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=808621
Benzinga · 4天前
子宫内膜异位症市场规模2021:顶级制造商的业务分析,最新技术,需求状况,份额估计,区域增长概述以及对2025的预测
Apr 07, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The “Endometriosis Market” research report...
The Express Wire · 5天前
图雷特综合症药物市场到2027年行业增长,趋势,主要参与者和主要地区的最新研究
Apr 06, 2021 (Market Insight Reports) -- CANADA - QYResearchMedical recently added a research report, Tourette Syndrome Drug market – global industry size,...
Market Insight Reports · 6天前
基本震颤治疗市场增长,规模,2021年分析,按行业份额,业务战略,新兴需求,增长率,近期趋势,机遇和对2026年的预测
The Express Wire · 04/05 10:07
2021年全球去甲肾上腺素再吸收抑制剂市场规模,细分分析,趋势,增长率,主要国家和业务概况,发展状况,即将到来的挑战,制约因素和对2025的预测
Apr 01, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Norepinephrine Reuptake Inhibitor...
The Express Wire · 04/01 08:00
2021年4月最值得购买的股票?本周值得关注的4种生物技术股票
Mar 28, 2021 (StockMarket.com via COMTEX) -- Do You Have These Trending Biotech Stocks On Your Watchlist This Week? Biotech companies play a major role in...
StockMarket.com · 03/28 20:27
现在值得投资的顶级保健股? 4聚焦
Mar 26, 2021 (StockMarket.com via COMTEX) -- Are These The Best Health Care Stocks To Buy Before April 2021? No matter the state of the world, the health...
StockMarket.com · 03/26 12:54
DJ Neurocrine Biosciences将加入S&P MidCap 400,股价上涨12%
Dow Jones · 03/25 17:28
每日生物技术脉搏:百时美施贵宝的皮肤癌读数,Cellect罢工反向并购交易,熔岩疗法首次在纳斯达克上市
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 24)
Benzinga · 03/25 11:58
Zoladex市场2021年行业业务增长,需求分析,新兴趋势,关键参与者和到2026年的区域预测|精确度报告
Mar 25, 2021 (The Expresswire) -- Worldwide “Zoladex Market” 2021 research reports provide a 5 year pre-historic and forecast for the sector and include data...
The Express Wire · 03/25 05:36
DJ Neurocrine Biosciences将加入S&P MidCap 400,OI Glass移至S&P SmallCap 600
Dow Jones · 03/24 21:39
180生命科学公司首席执行官James Woody,MD,PhD向股东发出信
MENLO PARK, Mar 24, 2021 (GLOBE NEWSWIRE via COMTEX) -- MENLO PARK, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the...
GlobeNewswire · 03/24 12:31
全球多囊卵巢综合症(PCOS)治疗药物市场规模,按发展分析,发展状况,到2025年的收入预期,工业研究业务的研究报告分担2021年的运动
Mar 24, 2021 (The Expresswire) -- Global “Polycystic Ovarian Syndrome (PCOS) Therapeutics Market” report is extensive significant analyses of the Polycystic...
The Express Wire · 03/24 06:29
2020-2027年全球Tourette综合征药物市场规模,份额,增长,趋势和预测| Ameco Research
pune, India, Tue, 23 Mar 2021 07:03:00 / Comserve Inc. / -- The "Global Tourette Syndrome Drug M - Market Analysis, Trends, and Forecasts" report has been...
Comserve · 03/23 11:04
微牛提供丰富的实时NBIX股票新闻,让你可以通过多个平台了解NBIX股票行情最新动态,这些免费的神经分泌生物科学新闻可以帮助你做出明智投资。
NBIX 简况
Neurocrine Biosciences, Inc.主要开发治疗神经和内分泌疾病和病症的药物。该公司两个主导的晚期临床计划是Elagolix和NBI-98854(valbenazine)。Elagolix是一种与AbbVie Inc.(AbbVie)合作开发出有利于女性健康的促性腺激素释放激素(GnRH)拮抗剂。NBI-98854(valbenazine)是一种用于治疗运动障碍的水泡单胺转运蛋白2(VMAT2)抑制剂。该公司专注于开发治疗特发性震颤的NBI-640756。其研究和开发专注于解决中枢神经和内分泌系统的疾病和病症,包括从下丘脑-垂体-肾上腺(HPA)病症到压力相关病症和神经/神经精神疾病的治疗类别。其促肾上腺皮质激素释放因子(CRF)是一种直接释放到垂体门静脉血管系统的下丘脑激素。